Publications by authors named "Kate Groot"

Claim this Profile
D
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Elmar Heinrich, Andrew V Schally, Stefan Buchholz, Ferenc G Rick, Gabor Halmos, Kate Groot

Prostate· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
Anton Stangelberger, Andrew V Schally, Marta Zarandi, Elmar Heinrich, Kate Groot

Prostate· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
Marta Zarandi, Jozsef L Varga, Andrew V Schally, Judit E Horvath, Gabor L Toller, Kate Groot

Proc Natl Acad Sci U S A· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.
Alexandre Havt, Andrew V Schally, Gabor Halmos, Jozsef L Varga, Gabor L Toller, Kate Groot

Proc Natl Acad Sci U S A· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Anton Stangelberger, Andrew V Schally, Jozsef L Varga, Brian D Hammann, Kate Groot

Prostate· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone.
Gunhild Keller, Andrew V Schally, Kate Groot, Gabor L Toller, Alexandre Havt

Proc Natl Acad Sci U S A· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone.
Jörg B Engel, Gunhild Keller, Andrew V Schally, Gabor L Toller, Kate Groot

J Clin Endocrinol Metab· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.
Gabor L Toller, Judit E Horvath, Andrew V Schally, Gabor Halmos, Jozsef L Varga, Kate Groot

Proc Natl Acad Sci U S A· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.
Judit E Horvath, Gabor L Toller, Andrew V Schally, Ana-Maria Bajo, Kate Groot

Proc Natl Acad Sci U S A· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.
Jozsef L Varga, Andrew V Schally, Judit E Horvath, Magdolna Kovacs, Gabor Halmos, Kate Groot

Proc Natl Acad Sci U S A· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.
Celia A Kanashiro, Andrew V Schally, Kate Groot, Patricia Armatis, Andrea L F Bernardino

Proc Natl Acad Sci U S A· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Zoltan Szereday, Andrew V Schally, Jozsef L Varga, Celia A Kanashiro, Francine Hebert, Kate Groot

Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
M Olga Garcia-Fernandez, Andrew V Schally, Jozsef L Varga, Kate Groot, Rebeca Busto

Breast Cancer Res Treat· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
Judit E Horvath, Ana M Bajo, Andrew V Schally, Magdolna Kovacs, Francine Herbert, Kate Groot

Proc Natl Acad Sci U S A· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Ryszard Braczkowski, Andrew V Schally, Artur Plonowski, Jozsef L Varga, Kate Groot

Cancer· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
Rebeca Busto, Andrew V Schally, Jozsef L Varga, M Olga Garcia-Fernandez, Kate Groot

Proc Natl Acad Sci U S A· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Artur Plonowski, Andrew V Schally, Markus Letsch, Magdalena Krupa, Francine Hebert, Kate Groot

Prostate· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.
Artur Plonowski, Jozsef L Varga, Andrew V Schally, Magdalena Krupa, Kate Groot

Int J Cancer· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
Ana M Bajo, Andrew V Schally, Magdalena Krupa, Francine Hebert, Kate Groot

Proc Natl Acad Sci U S A· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207.
Artur Plonowski, Andrew V Schally, Attila Nagy, Kate Groot, Magdalena Krupa

Cancer Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis